This is how Getinge creates value for society (ESG)
Business Areas' priorities to capture the opportunities
Finance supporting profitable growth
Page 3
What has happened since the CMD in 2018?
Getinge 2018-2021
Page 4
Getinge today
Leading positions in well defined segments
200 BSEK
CSSD*
Addressable market
Cath
Operating
ICU
90%
Lab
Room
4-6%
Hospitals represent 90% of sales,
Enabling advanced health care
Organic growth in addressable market
10% goes to Pharma, Lab & Medtech
where it matters the most
The value we contribute with
Improving
Improving
Reducing
Sales in 130 countries
29.8 BSEK
outcomes
efficiency
risk
to 25,000 customers
Net sales 2020
*Central Sterile Supply Department.
Page 5
Attachments
Original Link
Original Document
Permalink
Disclaimer
Getinge AB published this content on 22 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 November 2021 13:24:08 UTC.
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows:
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications.
Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%).
At the end of 2021, the group had 20 production sites worldwide.
Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
GETINGE AB 
